The research and main problems (2018):
1.From the perspective of our overall health care system, the problem with HIV diagnosis and treatment is that it is costly for the system. It is also debilitative and traumatic for individuals and families.
2. The most effective existing treatment to prevent HIV infection is PrEP. The key here is to understand that it is very effective if taken regularly. Pre-exposure prophylaxis, or PrEP, is a way for people who do not have HIV but who are at substantial risk of getting it to prevent HIV infection by taking a pill every day. The pill (brand name Truvada) contains two medicines (tenofovir and emtricitabine) that are used in combination with other medicines to treat HIV. When someone is exposed to HIV through sex or injection drug use, these medicines can work to keep the virus from establishing a permanent infection.
3. When taken consistently, PrEP has been shown to reduce the risk of HIV infection in people who are at high risk by up to 92%. PrEP is much less effective if it is not taken consistently. PrEP is a powerful HIV prevention tool and can be combined with condoms and other prevention methods to provide even greater protection than when used alone. But people who use PrEP must commit to taking the drug every day and seeing their health care provider for follow-up every 3 months.
Idea (2018):
1. When it comes to the rationale for going with an app based approach, we really looked to build off of existing evidence that technology is effective for changing behaviors like adherence.
2.Specifically, we look at studies that implemented text reminders among PrEP users. These studies found that text reminders led to a 15% increase in PrEP adherence.
3.This evidence is our justification for the app. We believe that if something as simple as text messages has been proven to work, an app should do a whole lot better.
Back to Top